TY - JOUR
T1 - Comorbid Psychiatric Disorders in Patients Hospitalized for Pulmonary Embolism and Acute Myocardial Infarction
T2 - A Japanese Nationwide Database Study
AU - Takahashi, Kie
AU - Uchida, Hiroyuki
AU - Suzuki, Takefumi
AU - Mimura, Masaru
AU - Ishida, Takuto
N1 - Funding Information:
The authors appreciate Ms Ai Gounaridis, Department of Neuropsychiatry, Keio University School of Medicine, for her dedicated administrative contribution to the present work. Ms Gounaridis has nothing to disclose.
Funding Information:
Submitted: February 26, 2021; accepted June 22, 2021. Published online: November 9, 2021. Potential conflicts of interest: Dr Uchida has received grants from Eisai, Otsuka, Dainippon-Sumitomo, and Meiji-Seika; speaker’s honoraria from Otsuka, Dainippon-Sumitomo, Eisai, and Meiji-Seika; and advisory panel payments from Dainippon-Sumitomo within the past 3 years. Dr Suzuki has received manuscript or speaker’s fees from Astellas, Dainippon Sumitomo, Eisai, Eli Lilly, Elsevier Japan, Janssen, Kyowa Yakuhin, Meiji Seika, Mitsubishi Tanabe, MSD, Nihon Medi-Physics, Novartis, Otsuka, Shionogi, Shire, Tsumura, Wiley Japan, and Yoshitomi Yakuhin and research grants from Eisai, Mochida, Meiji Seika, and Shionogi. Dr Mimura has received speaker’s honoraria from Byer, Daiichi Sankyo, Dainippon-Sumitomo, Eisai, Eli Lilly, Fuji Film RI, Hisamitsu, Janssen, Kyowa, Mochida, MSD, Mylan EPD, Nihon Medi-Physics, Nippon Chemipher, Novartis, Ono Yakuhin, Otsuka, Pfizer, Santen, Shire Japan, Takeda Yakuhin, Tsumura, and Yoshitomi Yakuhin within the past 3 years. Also, he received grants from Daiichi Sankyo, Eisai, Pfizer, Shionogi, Takeda, Tanabe Mitsubishi, and Tsumura within the past 3 years outside the submitted work. Dr Ishida has received a manuscript fee Dainippon-Sumitomo within the past 3 years. Dr Takahashi has nothing to disclose. Funding/support: None. Previous presentation: None. Acknowledgments: The authors appreciate Ms Ai Gounaridis, Department of Neuropsychiatry, Keio University School of Medicine, for her dedicated administrative contribution to the present work. Ms Gounaridis has nothing to disclose.
Publisher Copyright:
© Copyright 2021 Physicians Postgraduate Press, Inc.
PY - 2022/1
Y1 - 2022/1
N2 - Objective: While the most common cause of sudden cardiac arrest (SCA) in the general population is ischemic cardiac disease including acute myocardial infarction (AMI), previous preliminary data highlighted pulmonary embolism (PE) as a common cause of SCA among psychiatric patients. The aim of this study was to examine the proportion of patients with comorbid psychiatric disorders among patients hospitalized for either AMI or PE using a Japanese nationwide database. Methods: This study used Diagnosis Procedure Combination (DPC) data between April 2013 and March 2018 provided by the Ministry of Health, Labor, and Welfare. The DPC data included information on the causes of hospitalization and comorbidities of psychiatric diseases among inpatients in all acute care hospitals in Japan. The proportions of patients with schizophrenia (ICD-10 code F20), mood disorders (F31 or F32), and no psychiatric disorders were analyzed among patients who were hospitalized for AMI and PE. Results: The data from 351,159 AMI patients (mean age = 70.3 years) and 52,036 PE patients (mean age = 69.2 years) were used. Mortality rates were 8.0%–14.4% in AMI patients and 4.3%–9.8% in PE patients. The AMI group was predominantly male. The proportions of patients with schizophrenia and mood disorder were significantly higher in the PE group than in the AMI group (schizophrenia: 2.53% [1,314/52,036] vs 0.55% [1,922/351,159], P< .001; mood disorder: 2.94% [1,532/52,036] vs 0.60% [2,099/351,159], P< .001). Conclusions: The results highlight the importance of PE as a major cause of SCA in this specific population and the need for preventive measures to mitigate the mortality gap among patients with psychiatric disorders.
AB - Objective: While the most common cause of sudden cardiac arrest (SCA) in the general population is ischemic cardiac disease including acute myocardial infarction (AMI), previous preliminary data highlighted pulmonary embolism (PE) as a common cause of SCA among psychiatric patients. The aim of this study was to examine the proportion of patients with comorbid psychiatric disorders among patients hospitalized for either AMI or PE using a Japanese nationwide database. Methods: This study used Diagnosis Procedure Combination (DPC) data between April 2013 and March 2018 provided by the Ministry of Health, Labor, and Welfare. The DPC data included information on the causes of hospitalization and comorbidities of psychiatric diseases among inpatients in all acute care hospitals in Japan. The proportions of patients with schizophrenia (ICD-10 code F20), mood disorders (F31 or F32), and no psychiatric disorders were analyzed among patients who were hospitalized for AMI and PE. Results: The data from 351,159 AMI patients (mean age = 70.3 years) and 52,036 PE patients (mean age = 69.2 years) were used. Mortality rates were 8.0%–14.4% in AMI patients and 4.3%–9.8% in PE patients. The AMI group was predominantly male. The proportions of patients with schizophrenia and mood disorder were significantly higher in the PE group than in the AMI group (schizophrenia: 2.53% [1,314/52,036] vs 0.55% [1,922/351,159], P< .001; mood disorder: 2.94% [1,532/52,036] vs 0.60% [2,099/351,159], P< .001). Conclusions: The results highlight the importance of PE as a major cause of SCA in this specific population and the need for preventive measures to mitigate the mortality gap among patients with psychiatric disorders.
UR - http://www.scopus.com/inward/record.url?scp=85136597126&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85136597126&partnerID=8YFLogxK
U2 - 10.4088/JCP.21m13962
DO - 10.4088/JCP.21m13962
M3 - Article
AN - SCOPUS:85136597126
VL - 83
JO - Diseases of the Nervous System
JF - Diseases of the Nervous System
SN - 0160-6689
IS - 1
M1 - 21m13962
ER -